Back to results
US 2026/0085098 A1Published application
Method for the treatment of an acute respiratory distress syndrome
AssigneeRevolo Biotherapeutics Limited
InventorsAndrew Lightfoot, Nicola Cooper, Donata Federici Canova, Roly Foulkes
Life of this patent
Estimating the term…
Abstract
The present invention relates to a method for the acute treatment of a relapsing-remitting condition, the method comprising the step of administering to a subject in need thereof one or more doses of an effective amount of a peptide molecule as defined in claim 1 in response to or during a relapse, wherein the method causes remission of the condition.
Claims20
A method for acute treatment of an acute respiratory distress syndrome (ARDS) associated with a respiratory infection, the method comprising the steps of:
- (a) administering to a subject in need thereof one or more doses of an effective amount of a peptide molecule, the peptide molecule comprising an amino acid sequence as set forth in SEQ ID NO:
- 1, or having more than 95% identity to the amino acid sequence as set forth in SEQ ID NO:
- 1, wherein the acute treatment method causes remission of the ARDS in the subject;
- and
- (b) stopping the administration of the peptide molecule upon remission of the ARDS.
2 more elements
Dependencies are inferred from the claim text.